{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:16:28Z","timestamp":1772781388594,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T00:00:00Z","timestamp":1123718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1007\/s00401-005-1034-4","type":"journal-article","created":{"date-parts":[[2005,8,10]],"date-time":"2005-08-10T15:46:04Z","timestamp":1123688764000},"page":"232-238","source":"Crossref","is-referenced-by-count":50,"title":["Redox metals and oxidative abnormalities in human prion diseases"],"prefix":"10.1007","volume":"110","author":[{"given":"Robert B.","family":"Petersen","sequence":"first","affiliation":[]},{"given":"Sandra L.","family":"Siedlak","sequence":"additional","affiliation":[]},{"given":"Hyoung-gon","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Yong-Sun","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Akihiko","family":"Nunomura","sequence":"additional","affiliation":[]},{"given":"Fabrizio","family":"Tagliavini","sequence":"additional","affiliation":[]},{"given":"Bernardino","family":"Ghetti","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Cras","sequence":"additional","affiliation":[]},{"given":"Paula I.","family":"Moreira","sequence":"additional","affiliation":[]},{"given":"Rudy J.","family":"Castellani","sequence":"additional","affiliation":[]},{"given":"Marin","family":"Guentchev","sequence":"additional","affiliation":[]},{"given":"Herbert","family":"Budka","sequence":"additional","affiliation":[]},{"given":"James W.","family":"Ironside","sequence":"additional","affiliation":[]},{"given":"Pierluigi","family":"Gambetti","sequence":"additional","affiliation":[]},{"given":"Mark A.","family":"Smith","sequence":"additional","affiliation":[]},{"given":"George","family":"Perry","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2005,8,11]]},"reference":[{"key":"1034_CR1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/37783","volume":"390","author":"Brown","year":"1997","unstructured":"Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, Bohlen A von, Schulz-Schaeffer W, Giese A, Westaway D, Kretzschmar H (1997) The cellular prion protein binds copper in vivo. Nature 390:684\u2013687","journal-title":"Nature"},{"key":"1034_CR2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1750-3639.1995.tb00625.x","volume":"5","author":"Budka","year":"1995","unstructured":"Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Gullotta F, Haltia M, Hauw JJ, Ironside JW, Jellinger K (1995) Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5:459\u2013466","journal-title":"Brain Pathol"},{"key":"1034_CR3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00005072-199301000-00008","volume":"52","author":"Bugiani","year":"1993","unstructured":"Bugiani O, Giaccone G, Verga L, Pollo B, Frangione B, Farlow MR, Tagliavini F, Ghetti B (1993) Beta PP participates in PrP-amyloid plaques of Gerstmann-Straussler-Scheinker disease, Indiana kindred. J Neuropathol Exp Neurol 52:64\u201370","journal-title":"J Neuropathol Exp Neurol"},{"key":"1034_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0891-5849(01)00570-6","volume":"31","author":"Castellani","year":"2001","unstructured":"Castellani RJ, Harris PL, Sayre LM, Fujii J, Taniguchi N, Vitek MP, Founds H, Atwood CS, Perry G, Smith MA (2001) Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. Free Radic Biol Med 31:175\u2013180","journal-title":"Free Radic Biol Med"},{"key":"1034_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.55782\/ane-2004-1487","volume":"Exp","author":"Castellani","year":"2004","unstructured":"Castellani RJ, Perry G, Smith MA (2004) Prion disease and Alzheimer\u2019s disease: pathogenic overlap. Acta Neurobiol Exp (Wars) 64:11\u201317","journal-title":"Acta Neurobiol"},{"key":"1034_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/13506120009146813","volume":"7","author":"DeArmond","year":"2000","unstructured":"DeArmond SJ (2000) Cerebral amyloidosis in prion diseases. Amyloid 7:3\u20136","journal-title":"Amyloid"},{"key":"1034_CR7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.molbrainres.2004.10.018","volume":"133","author":"Fernaeus","year":"2005","unstructured":"Fernaeus S, Halldin J, Bedecs K, Land T (2005) Changed iron regulation in scrapie-infected neuroblastoma cells. Brain Res Mol Brain Res 133:266\u2013273","journal-title":"Brain Res Mol Brain Res"},{"key":"1034_CR8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s004010050949","volume":"97","author":"Ferrer","year":"1999","unstructured":"Ferrer I (1999) Nuclear DNA fragmentation in Creutzfeldt-Jakob disease: does a mere positive in situ nuclear end-labeling indicate apoptosis? Acta Neuropathol 97:5\u201312","journal-title":"Acta Neuropathol"},{"key":"1034_CR9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","volume":"66","author":"Gambetti","year":"2003","unstructured":"Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66:213\u2013239","journal-title":"Br Med Bull"},{"key":"1034_CR10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.39.11.1453","volume":"39","author":"Ghetti","year":"1989","unstructured":"Ghetti B, Tagliavini F, Masters CL, Beyreuther K, Giaccone G, Verga L, Farlow MR, Conneally PM, Dlouhy SR, Azzarelli B (1989) Gerstmann-Straussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 39:1453-1461","journal-title":"Neurology"},{"key":"1034_CR11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0272-2712(02)00064-1","volume":"23","author":"Ghetti","year":"2003","unstructured":"Ghetti B, Tagliavini F, Takao M, Bugiani O, Piccardo P (2003) Hereditary prion protein amyloidoses. Clin Lab Med 23:65\u201385, viii","journal-title":"Clin Lab Med"},{"key":"1034_CR12","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0002-9440(10)65459-4","volume":"155","author":"Guentchev","year":"1999","unstructured":"Guentchev M, Wanschitz J, Voigtlander T, Flicker H, Budka H (1999) Selective neuronal vulnerability in human prion diseases. Fatal familial insomnia differs from other types of prion diseases. Am J Pathol 155:1453\u20131457","journal-title":"Am J Pathol"},{"key":"1034_CR13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/nbdi.2000.0290","volume":"7","author":"Guentchev","year":"2000","unstructured":"Guentchev M, Voigtlander T, Haberler C, Groschup MH, Budka H (2000) Evidence for oxidative stress in experimental prion disease. Neurobiol Dis 7:270\u2013273","journal-title":"Neurobiol Dis"},{"key":"1034_CR14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/nbdi.2002.0477","volume":"9","author":"Guentchev","year":"2002","unstructured":"Guentchev M, Siedlak SL, Jarius C, Tagliavini F, Castellani RJ, Perry G, Smith MA, Budka H (2002) Oxidative damage to nucleic acids in human prion disease. Neurobiol Dis 9:275\u2013281","journal-title":"Neurobiol Dis"},{"key":"1034_CR15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jmb.2003.12.004","volume":"336","author":"Hall","year":"2004","unstructured":"Hall D, Edskes H (2004) Silent prions lying in wait: a two-hit model of prion\/amyloid formation and infection. J Mol Biol 336:775\u2013786","journal-title":"J Mol Biol"},{"key":"1034_CR16","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"Hirai","year":"2001","unstructured":"Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer\u2019s disease. J Neurosci 21:3017\u20133023","journal-title":"J Neurosci"},{"key":"1034_CR17","doi-asserted-by":"crossref","unstructured":"Honda K, Smith MA, Zhu X, Baus D, Merrick WC, Tartakoff AM, Hattier T, Harris PL, Siedlak SL, Fujioka H, Liu Q, Moreira PI, Miller FP, Nunomura A, Shimohama S, Perry G (2005) Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J Biol Chem [Mar 14; Epub ahead of print]","DOI":"10.1074\/jbc.M500526200"},{"key":"1034_CR18","first-page":"143","volume":"Suppl","author":"Ironside","year":"2000","unstructured":"Ironside JW (2000) Pathology of variant Creutzfeldt-Jakob disease. Arch Virol Suppl (16):143\u2013151","journal-title":"Arch Virol"},{"key":"1034_CR19","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1128\/JVI.61.12.3688-3693.1987","volume":"61","author":"Kascsak","year":"1987","unstructured":"Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM, Diringer H (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61:3688\u20133693","journal-title":"J Virol"},{"key":"1034_CR20","first-page":"799","volume":"8","author":"Klatzo","year":"1959","unstructured":"Klatzo I, Gajdusek DC, Zigas V (1959) Pathology of Kuru. Lab Invest 8:799\u2013847","journal-title":"Lab Invest"},{"key":"1034_CR21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/bmb\/66.1.267","volume":"66","author":"Kubler","year":"2003","unstructured":"Kubler E, Oesch B, Raeber AJ (2003) Diagnosis of prion diseases. Br Med Bull 66:267\u2013279","journal-title":"Br Med Bull"},{"key":"1034_CR22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0197-0186(96)00153-2","volume":"31","author":"Lucas","year":"1997","unstructured":"Lucas M, Izquierdo G, Munoz C, Solano F (1997) Internucleosomal breakdown of the DNA of brain cortex in human spongiform encephalopathy. Neurochem Int 31:241\u2013244","journal-title":"Neurochem Int"},{"key":"1034_CR23","doi-asserted-by":"crossref","first-page":"11280","DOI":"10.1523\/JNEUROSCI.2864-04.2004","volume":"24","author":"Mishra","year":"2004","unstructured":"Mishra RS, Basu S, Gu Y, Luo X, Zou WQ, Mishra R, Li R, Chen SG, Gambetti P, Fujioka H, Singh N (2004) Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci 24:11280\u201311290","journal-title":"J Neurosci"},{"key":"1034_CR24","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","volume":"19","author":"Nunomura","year":"1999","unstructured":"Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer\u2019s disease. J Neurosci 19:1959\u20131964","journal-title":"J Neurosci"},{"key":"1034_CR25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jnen\/59.11.1011","volume":"59","author":"Nunomura","year":"2000","unstructured":"Nunomura A, Perry G, Pappolla MA, Friedland RP, Hirai K, Chiba S, Smith MA (2000) Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol 59:1011\u20131017","journal-title":"J Neuropathol Exp Neurol"},{"key":"1034_CR26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00023210-200216050-00006","volume":"16","author":"Perry","year":"2002","unstructured":"Perry G, Sayre LM, Atwood CS, Castellani RJ, Cash AD, Rottkamp CA, Smith MA (2002) The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 16:339\u2013352","journal-title":"CNS Drugs"},{"key":"1034_CR27","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/00005072-199511000-00006","volume":"54","author":"Piccardo","year":"1995","unstructured":"Piccardo P, Ghetti B, Dickson DW, Vinters HV, Giaccone G, Bugiani O, Tagliavini F, Young K, Dlouhy SR, Seiler C, et al (1995) Gerstmann-Straussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90\u2013165. J Neuropathol Exp Neurol 54:790\u2013801","journal-title":"J Neuropathol Exp Neurol"},{"key":"1034_CR28","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363\u201313383","journal-title":"Proc Natl Acad Sci USA"},{"key":"1034_CR29","doi-asserted-by":"crossref","first-page":"9064","DOI":"10.1074\/jbc.M211830200","volume":"278","author":"Rachidi","year":"2003","unstructured":"Rachidi W, Vilette D, Guiraud P, Arlotto M, Riondel J, Laude H, Lehmann S, Favier A (2003) Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem 278:9064\u20139072","journal-title":"J Biol Chem"},{"key":"1034_CR30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jnr.10864","volume":"75","author":"Roucou","year":"2004","unstructured":"Roucou X, Gains M, LeBlanc AC (2004) Neuroprotective functions of prion protein. J Neurosci Res 75:153\u2013161","journal-title":"J Neurosci Res"},{"key":"1034_CR31","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","volume":"68","author":"Sayre","year":"1997","unstructured":"Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer\u2019s disease. J Neurochem 68:2092\u20132097","journal-title":"J Neurochem"},{"key":"1034_CR32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0076-6879(99)09012-6","volume":"309","author":"Sayre","year":"1999","unstructured":"Sayre LM, Perry G, Smith MA (1999) In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders. Methods Enzymol 309:133\u2013152","journal-title":"Methods Enzymol"},{"key":"1034_CR33","unstructured":"Sayre LM, Perry G, Atwood CS, Smith MA (2000) The role of metals in neurodegenerative diseases. Cell Mol Biol (Noisy-le-grand) 46:731\u2013741"},{"key":"1034_CR34","doi-asserted-by":"crossref","first-page":"46199","DOI":"10.1074\/jbc.C300303200","volume":"278","author":"Sigurdsson","year":"2003","unstructured":"Sigurdsson EM, Brown DR, Alim MA, Scholtzova H, Carp R, Meeker HC, Prelli F, Frangione B, Wisniewski T (2003) Copper chelation delays the onset of prion disease. J Biol Chem 278:46199\u201346202","journal-title":"J Biol Chem"},{"key":"1034_CR35","first-page":"42","volume":"145","author":"Smith","year":"1994","unstructured":"Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Chader GJ, Wiggert B, Petersen RB, Perry G (1994) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer\u2019s disease. Am J Pathol 145:42\u201347","journal-title":"Am J Pathol"},{"key":"1034_CR36","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1073\/pnas.94.18.9866","volume":"94","author":"Smith","year":"1997","unstructured":"Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94:9866\u20139868","journal-title":"Proc Natl Acad Sci USA"},{"key":"1034_CR37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/bj3620253","volume":"362","author":"Thackray","year":"2002","unstructured":"Thackray AM, Knight R, Haswell SJ, Bujdoso R, Brown DR (2002) Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem J 362:253\u2013258","journal-title":"Biochem J"},{"key":"1034_CR38","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1046\/j.1471-4159.2001.00522.x","volume":"78","author":"Wong","year":"2001","unstructured":"Wong BS, Chen SG, Colucci M, Xie Z, Pan T, Liu T, Li R, Gambetti P, Sy MS, Brown DR (2001) Aberrant metal binding by prion protein in human prion disease. J Neurochem 78:1400\u20131408","journal-title":"J Neurochem"},{"key":"1034_CR39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1471-4159.2001.00028.x","volume":"76","author":"Wong","year":"2001","unstructured":"Wong BS, Liu T, Li R, Pan T, Petersen RB, Smith MA, Gambetti P, Perry G, Manson JC, Brown DR, Sy MS (2001) Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 76:565\u2013572","journal-title":"J Neurochem"},{"key":"1034_CR40","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/mcne.2001.0963","volume":"17","author":"Wong","year":"2001","unstructured":"Wong BS, Liu T, Paisley D, Li R, Pan T, Chen SG, Perry G, Petersen RB, Smith MA, Melton DW, Gambetti P, Brown DR, Sy MS (2001) Induction of HO-1 and NOS in doppel-expressing mice devoid of PrP: implications for doppel function. Mol Cell Neurosci 17:768\u2013775","journal-title":"Mol Cell Neurosci"},{"key":"1034_CR41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0047-6374(01)00342-6","volume":"123","author":"Zhu","year":"2001","unstructured":"Zhu X, Castellani RJ, Takeda A, Nunomura A, Atwood CS, Perry G, Smith MA (2001) Differential activation of neuronal ERK, JNK\/SAPK and p38 in Alzheimer disease: the \u2018two hit\u2019 hypothesis. Mech Ageing Dev 123:39\u201346","journal-title":"Mech Ageing Dev"},{"key":"1034_CR42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1474-4422(04)00707-0","volume":"3","author":"Zhu","year":"2004","unstructured":"Zhu X, Raina AK, Perry G, Smith MA (2004) Alzheimer\u2019s disease: the two-hit hypothesis. Lancet Neurol 3:219\u2013226","journal-title":"Lancet Neurol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-005-1034-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-005-1034-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-005-1034-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T19:45:46Z","timestamp":1706471146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-005-1034-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,11]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["1034"],"URL":"https:\/\/doi.org\/10.1007\/s00401-005-1034-4","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,11]]}}}